Amount Raised
$60 Million
Round Type
Series B
ShanghaiBiotechnologyHealth CareTherapeuticsInvestors
Description
On September 8, 2023, Grit Biotechnology announced the completion of a Series B financing round, raising over 60 million USD. The investment was led by CICC with participation from Qianhai Ark, Liando Group, Yuanhe Capital, HeFangTian Venture Partnership and existing investors Sherpa Healthcare Partners, Decheng Capital and Matrix Partners China.
Quick answer
Grit Biotechnology raised $60 Million in a Series B round, dated September 8, 2023. Investors: Matrix Partners China, Decheng Capital, Sherpa Healthcare Partners, He Fang Tian Venture Partnership, Yuanhe Capital, Liando Group, Qianhai Ark and Cicc. Grit Biotechnology is based in Shanghai, Shanghai, China.
- How much did Grit Biotechnology raise?
- Grit Biotechnology raised $60 Million in a Series B round on September 8, 2023.
- Who invested in Grit Biotechnology?
- Matrix Partners China, Decheng Capital, Sherpa Healthcare Partners, He Fang Tian Venture Partnership, Yuanhe Capital, Liando Group, Qianhai Ark and Cicc are named as investors in this round.
- What does Grit Biotechnology do?
- Grit Bio is a Chinese cell therapy company founded in 2019.
- Where is Grit Biotechnology based and how big is it?
- Grit Biotechnology is based in Shanghai, Shanghai, China.
- Who are the decision-makers at Grit Biotechnology?
- Fundz holds 1 contact at Grit Biotechnology. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Grit Biotechnology that raised within 45 days of this round, from Fundz verified event records.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- Azora Therapeutics, Inc. (DE) raised $4M (Seed) on October 19, 2023.
- Actym Therapeutics raised $60M (Series A) on October 18, 2023.
- Amplifier Therapeutics raised an undisclosed amount (Funding Round) on October 17, 2023.
- Amicus Therapeutics raised an undisclosed amount (Funding Round) on October 2, 2023.
- Acasti raised $7.5M (Post-IPO Equity) on September 26, 2023.
Who to call at Grit Biotechnology, and when
A new round usually means Grit Biotechnology is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Grit Biotechnology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Grit Biotechnology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Grit Biotechnology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Grit Biotechnology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGrit Biotechnology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.